Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6–35 months: a randomized, double‐blind, controlled phase I clinical trial

Please cite this paper as: Li et al. (2012) Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6–35 months: a randomized, double‐blind, controlled phase I clinical trial. Influenza and Other Respiratory Viruses DOI: 10.1111/irv.12028. Objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan‐Ping, Li, Wei, Liang, Xiao‐Feng, Liu, Yan, Huang, Xiao‐Chun, Li, Chang‐Gui, Li, Rong‐Cheng, Wang, Jun‐Zhi, Wang, Hua‐Qing, Yin, Wei‐Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Part 5
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634301/
https://www.ncbi.nlm.nih.gov/pubmed/23134570
http://dx.doi.org/10.1111/irv.12028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634301/
https://www.ncbi.nlm.nih.gov/pubmed/23134570
http://dx.doi.org/10.1111/irv.12028

Ejemplares similares